当前位置： SCI文献检索 > THROMBOSIS AND HAEMOSTASIS期刊下所有文献 > Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.

Peptides inhibiting heparanase procoagulant activity significantly reduce tumour growth and vascularisation in a mouse model.

Abstract：

:Heparanase is implicated in angiogenesis and tumour progression. We previously demonstrated that heparanase might also affect the haemostatic system in a non-enzymatic manner. It forms a complex and enhances the activity of the blood coagulation initiator tissue factor (TF). Peptides that we generated from TF pathway inhibitor (TFPI)-2, which inhibit heparanase procoagulant activity, were recently demonstrated to attenuate inflammation in a sepsis mouse model. The present study was designated to explore peptides effects on tumour growth and vascularisation. Cell lines of mouse melanoma (B16), mouse breast cancer (EMT-6), and human breast cancer (MDA-231) were injected subcutaneously to mice. Inhibitory peptides 5, 6 and 7 were injected subcutaneously in the area opposite to the tumour side. In the three tumour cell lines, peptides 5, 6 and 7 inhibited tumour growth and vascularisation in a dose-dependent manner, reaching a 2/3 reduction compared to control tumours (p<0.001). Additionally, a survival advantage (p<0.05) and reduced plasma thrombin-antithrombin complex (p<0.05) were observed in the treatment groups. Peptides delayed tumour relapse by six days and inhibited relapsed tumour size (p<0.001). In vitro, peptides did not inhibit tumour cell proliferation, migration or heparanase degradation of heparan sulfate chains, but significantly decreased tube formation. In conclusion, peptides inhibiting heparanase procoagulant activity significantly reduced tumour growth, vascularisation, and relapse. The procoagulant domain in heparanase protein may play a role in tumour growth, suggesting a new mechanism of coagulation system involvement in cancer.

journal_name

Thromb Haemost

journal_title

Thrombosis and haemostasis

authors

Crispel Y,Axelman E,Tatour M,Kogan I,Nevo N,Brenner B,Nadir Y

doi

10.1160/TH16-02-0119

subject

Has Abstract

pub_date

2016-09-27 00:00:00

pages

669-78

issue

4

eissn

0340-6245

issn

2567-689X

pii

16-02-0119

journal_volume

116

pub_type

杂志文章

相关文献

THROMBOSIS AND HAEMOSTASIS文献大全
  • Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.

    abstract：:An algal sulfated galactan has high anticoagulant and antithrombotic activities. Its serpin-dependent anticoagulant action is due to promoting thrombin and factor (F)Xa inhibition by antithrombin and heparin cofactor II. Here, we evaluated the anticoagulant effect of the algal sulfated galactan using serpin-free plasm...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH09-04-0273

    authors： Glauser BF,Rezende RM,Melo FR,Pereira MS,Francischetti IM,Monteiro RQ,Rezaie AR,Mourão PA

    更新日期：2009-12-01 00:00:00

  • Tissue factor, protease activated receptors and pathologic heart remodelling.

    abstract：:Tissue factor is the primary initiator of coagulation cascade and plays an essential role in haemostasis and thrombosis. In addition, tissue factor and coagulation proteases contribute to many cellular responses via activation of protease activated receptors. The heart is an organ with high levels of constitutive tiss...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章,评审

    doi：10.1160/TH14-03-0243

    authors： Antoniak S,Sparkenbaugh E,Pawlinski R

    更新日期：2014-11-01 00:00:00

  • Hypercoagulable state in patients with Takayasu's arteritis.

    abstract：:Thrombus formation is recognized pathologically in the affected arteries and is supposed to play a major role in the pathogenesis of Takayasu's arteritis; however, hemostatic conditions in this disorder have not been elucidated fully. We determined plasma levels of molecular markers for platelet activity (platelet fac...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Akazawa H,Ikeda U,Yamamoto K,Kuroda T,Shimada K

    更新日期：1996-05-01 00:00:00

  • Anti-thrombotic effects of selective estrogen receptor modulator tamoxifen.

    abstract：:Tamoxifen is a known anti-cancer drug and established estrogen receptor modulator. Few clinical studies have earlier implicated the drug in thrombotic complications attributable to lower anti-thrombin and protein S levels in plasma. However, action of tamoxifen on platelet signalling machinery has not been elucidated ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH11-03-0178

    authors： Nayak MK,Singh SK,Roy A,Prakash V,Kumar A,Dash D

    更新日期：2011-10-01 00:00:00

  • Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.

    abstract：:Tissue-type plasminogen activator (t-PA) is a fibrin-specific agent which is used to treat acute myocardial infarction. Pharmacokinetically, t-PA is characterized by a rapid clearance from the circulation. In a previous study, we constructed variant forms of t-PA with genetic modifications at the fibronectin finger-li...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Yahara H,Matsumoto K,Maruyama H,Nagaoka T,Ikenaka Y,Yajima K,Fukao H,Ueshima S,Matsuo O

    更新日期：1994-12-01 00:00:00

  • The use of evacuated tubes for blood collection in oral anticoagulant control.

    abstract：:The prothrombin time (PT) test is used to monitor oral anticoagulant therapy. Contact activation of patient blood samples in vitro may shorten the PT and thus lead to underestimation of the degree of anticoagulation. Commercial evacuated tubes for blood collection have been reported to induce shortening of the PT. The...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： van den Besselaar AM,van Halem-Visser LP,Loeliger EA

    更新日期：1983-10-31 00:00:00

  • Benefit-risk profile of non-vitamin K antagonist oral anticoagulants in the management of venous thromboembolism.

    abstract：:The prevention and treatment of venous thromboembolism (VTE) remains a clinical challenge, primarily owing to drawbacks associated with the use of heparins and vitamin K antagonists (VKAs). These and other factors, including a growing elderly population, mean that VTE presents a continuing burden to patients and physi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章,meta分析,评审

    doi：10.1160/TH14-06-0484

    authors： Beyer-Westendorf J,Ageno W

    更新日期：2015-02-01 00:00:00

  • Oh Heavy Burden: Recognizing the Risk of Venous Thromboembolism in Women Undergoing Assisted Reproduction.

    abstract：: ...

    journal_title：Thrombosis and haemostasis

    pub_type： 社论

    doi：10.1055/s-0038-1676073

    authors： Piazza G

    更新日期：2018-12-01 00:00:00

  • Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.

    abstract：:It has been experimentally shown that endotoxin induces a significant increase in the blood levels of a plasminogen activator inhibitor (PAI). We evaluated the effect of different doses of heparin (5 to 20 IU kg-1 h-1), antithrombin III (10 to 40 U kg-1 h-1 and 240 U/kg as bolus) and of a combination of the two on: 1)...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Gómez C,Páramo JA,Colucci M,Rocha E

    更新日期：1989-09-29 00:00:00

  • Factor VII Toyama (Thr 359 Met): a homozygous missense mutation causing severe type I deficiency.

    abstract：:We performed a DNA analysis on a patient with severe type I factor VII deficiency by the polymerase chain reaction amplification and a direct DNA sequencing method. The proband was a 66-year-old Japanese woman who had recurrent episodes of excessive bleeding after dental extraction. The functional and antigenic levels...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Ozawa T,Niiya K,Higuchi W,Sakuragawa N

    更新日期：1997-09-01 00:00:00

  • Antithrombin III: a database of mutations.

    abstract：:Elucidation of the molecular defects responsible for antithrombin III deficiency is proceeding rapidly. In order that a record is kept of the new and duplicated mutations that are found, we have compiled a database that we plan to update annually. In this, the first report of the database, we list 6 antithrombin III l...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Lane DA,Ireland H,Olds RJ,Thein SL,Perry DJ,Aiach M

    更新日期：1991-12-02 00:00:00

  • International collaborative study for the establishment of the second International Reference Preparation of plasmin.

    abstract：:An international collaborative study involving seven laboratories was undertaken to assess the suitability of a freeze-dried preparation of human plasmin to replace the current International Reference Preparation (IRP) for plasmin. Chromogenic and fibrinolytic assays were used by all participating laboratories to asse...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Gaffney PJ,Mussett MV

    更新日期：1983-10-31 00:00:00

  • Influence of variability of interpretation of contrast venography for screening of postoperative deep venous thrombosis on the results of a thromboprophylactic study.

    abstract：:To assess interobserver variability of venography for screening for postoperative deep venous thrombosis (DVT), we used 185 bilateral ascending contrast venograms (366 lower limbs) which were performed using the long-leg film technique, in the frame of a trial of the efficacy of two low-molecular-weight-heparin fracti...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章

    doi：

    authors： Couson F,Bounameaux C,Didier D,Geiser D,Meyerovitz MF,Schmitt HE,Schneider PA,Bounameaux H

    更新日期：1993-10-18 00:00:00

  • Coagulation factor XII regulates inflammatory responses in human lungs.

    abstract：:Increased procoagulant activity in the alveolar compartment and uncontrolled inflammation are hallmarks of the acute respiratory distress syndrome (ARDS). Here, we investigated whether the contact phase system of coagulation is activated and may regulate inflammatory responses in human lungs. Components of the contact...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH16-12-0904

    authors： Hess R,Wujak L,Hesse C,Sewald K,Jonigk D,Warnecke G,Fieguth HG,de Maat S,Maas C,Bonella F,Preissner KT,Weiss B,Schaefer L,Kuebler WM,Markart P,Wygrecka M

    更新日期：2017-10-05 00:00:00

  • Baboon models of acute arterial thrombosis.

    abstract：:In conclusion, we believe that the baboon offers many advantages as an experimental animal to study vascular disease, thrombus formation and dissolution, the effects of mediating variables, and the relative efficacy of therapeutic interventions. Each specific application for testing therapeutic agents may require test...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章,评审

    doi：

    authors： Hanson SR,Harker LA

    更新日期：1987-10-28 00:00:00

  • Effects of intermittent pneumatic calf compression on postoperative thrombin and plasmin activity.

    abstract：:A previous study of neurosurgical patients demonstrated an imbalance between thrombin and plasmin action following surgery. The present study was designed to determine the effect of intermittent pneumatic calf compression on postoperative enzyme activity. Fibrinopeptide A (FPA) and B beta 1-42 levels, reflecting throm...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Weitz J,Michelsen J,Gold K,Owen J,Carpenter D

    更新日期：1986-10-21 00:00:00

  • Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome.

    abstract：:Our aim was to demonstrate that the sequential use of the Verigene® rapid CYP2C19 test for genetic profiling and the VerifyNowTM bedside test for platelet function measurement in ACS patients may optimise P2Y12 inhibition. "Rapid" (CYP2C19*1/*1 or CYP2C19*17 carriers, n=211) and "slow" metabolisers (CYP2C19*2 carriers...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章,多中心研究

    doi：10.1160/TH15-05-0394

    authors： Collet JP,Kerneis M,Hulot JS,O'Connor SA,Silvain J,Mansencal N,Brugier D,Abtan J,Barthélémy O,Vignalou JB,Payot L,Rousseau H,Vicaut E,Montalescot G,GAMMA Investigators.

    更新日期：2016-01-01 00:00:00

  • Induction of endothelial tissue factor by endotoxin and its precursors.

    abstract：:The structural determinants of lipopolysaccharide required for the induction of tissue factor in human umbilical vein endothelial cells were studied. Intact lipid A was essential for the induction of tissue factor whereas the incomplete lipid A precursors lipid IVA and lipid X, as well as monophosphoryl lipid A and ac...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Moldow CF,Bach RR,Staskus K,Rick PD

    更新日期：1993-10-18 00:00:00

  • C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study.

    abstract：:Previous studies have shown an association between serum C-reactive protein (CRP) and cardiovascular disease (CVD) risk. The roles of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNFalpha) are less well established. The aim of the present study was to analyze the associations of CRP, IL-6 and TNFalpha with in...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH05-08-0571

    authors： Tuomisto K,Jousilahti P,Sundvall J,Pajunen P,Salomaa V

    更新日期：2006-03-01 00:00:00

  • Molecular weight measurements of low molecular weight heparins by gel permeation chromatography.

    abstract：:The molecular weight profiles of low molecular weight heparin samples have been measured by high-performance gel permeation chromatography using as calibrant the heparinase-degraded material (90/686) now established as the 1st International Reference Preparation (IRP) Low Molecular Weight Heparin for Molecular Weight ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Mulloy B,Gee C,Wheeler SF,Wait R,Gray E,Barrowcliffe TW

    更新日期：1997-04-01 00:00:00

  • Inhibitor to factor VIII in mild haemophilia.

    abstract：:Factor VIII inhibitors in mild haemophilia are uncommon and the management of such patients is controversial. The development of a persistently high responding F VIII inhibitor in a mild haemophiliac is reported and the behaviour of the inhibitor discussed in the context of the various therapeutic regimes employed for...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Kesteven PJ,Holland LJ,Lawrie AS,Savidge GF

    更新日期：1984-08-31 00:00:00

  • Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population--II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions.

    abstract：:In a preceding paper the baseline data in the Münster Arteriosclerosis Study (PROCAM study) of the levels of fibrinogen, factor VIIc and factor VIIIc were described, and their correlation of age, body weight, smoking, alcohol, pill-using and menopause discussed. In this part the relationship of these coagulation facto...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Balleisen L,Assmann G,Bailey J,Epping PH,Schulte H,van de Loo J

    更新日期：1985-10-30 00:00:00

  • Response of femoral venous oxygen tension to graduated pressure stockings--possible relationship to deep vein thrombosis.

    abstract：:Venous oxygen tension (pO2) was measured in discrete samples of blood obtained through the femoral vein of cardiac catheterisation patients before, during and after application of sustained external graduated pressure in the form of compression stockings (T. E. D. Kendall). There was a significant reduction (p less th...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Okoye GC,Evans JH,Beattie J,Lowe GD,Lorimer AR,Forbes CD

    更新日期：1984-02-28 00:00:00

  • An experimental model of intracranial hemorrhage during thrombolytic therapy with t-PA.

    abstract：:Multiple clinical trials have proven that thrombolytic therapy is an effective treatment for acute myocardial infarction. Spontaneous intracranial hemorrhage (ICH) occurs in a small percentage of patients as a result of the treatment. The etiology of the ICH is unknown and there is currently no established experimenta...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Paoni NF,Steinmetz HG,Gillett N,Refino CJ,Badillo JM,Bunting S

    更新日期：1996-05-01 00:00:00

  • Platelet function and the bleeding time in progressive renal failure.

    abstract：:Bleeding time and platelet function tests were performed on 31 patients with progressive chronic renal failure (CRF) due to non-immunological (urological) causes, and compared with 22 healthy controls. Patients were classified as mild (plasma creatinine less than 300 mumol/l), moderate (300-600 mumol/l) or severe rena...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Gordge MP,Faint RW,Rylance PB,Neild GH

    更新日期：1988-08-30 00:00:00

  • Premature arterial disease associated with familial antithrombin III deficiency.

    abstract：:Antithrombin III (ATIII) deficiency is one of the few known abnormalities of the coagulation system known to predispose to venous thromboembolism but its relation to arterial disease is not established. We describe two related patients with this disorder, both of whom suffered arterial thrombotic events, at an early a...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：

    authors： Johnson EJ,Prentice CR,Parapia LA

    更新日期：1990-02-19 00:00:00

  • Plasminogen is a critical regulator of cutaneous wound healing.

    abstract：:Wound healing is a complicated biological process that consist of partially overlapping inflammatory, proliferation and tissue remodelling phases. A successful wound healing depends on a proper activation and subsequent termination of the inflammatory phase. The failure to terminate the inflammation halts the completi...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH15-08-0653

    authors： Sulniute R,Shen Y,Guo YZ,Fallah M,Ahlskog N,Ny L,Rakhimova O,Broden J,Boija H,Moghaddam A,Li J,Wilczynska M,Ny T

    更新日期：2016-05-02 00:00:00

  • Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial.

    abstract：:In patients with atrial fibrillation (AF) who require interruption of dabigatran or warfarin for an elective surgery/procedure, the risks and benefits of perioperative bridging anticoagulation is uncertain.We accessed the database from RE-LY, a randomised trial comparing dabigatran with warfarin for stroke prevention ...

    journal_title：Thrombosis and haemostasis

    pub_type： 杂志文章

    doi：10.1160/TH14-04-0305

    authors： Douketis JD,Healey JS,Brueckmann M,Eikelboom JW,Ezekowitz MD,Fraessdorf M,Noack H,Oldgren J,Reilly P,Spyropoulos AC,Wallentin L,Connolly SJ

    更新日期：2015-03-01 00:00:00

  • Surgical evaluation of a recombinant factor VIII prepared using a plasma/albumin-free method: efficacy and safety of Advate in previously treated patients.

    abstract：:Evaluation of factor F(V)III replacement in patients with haemophilia A undergoing surgery is critical for FVIII concentrates, yet large scale, multi-center prospective studies, particularly using continuous infusion, are generally lacking for new products. This study evaluated efficacy and safety of a newly developed...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章,多中心研究

    doi：

    authors： Négrier C,Shapiro A,Berntorp E,Pabinger I,Tarantino M,Retzios A,Schroth P,Ewenstein B

    更新日期：2008-08-01 00:00:00

  • A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.

    abstract：BACKGROUND:Recombinant hirudin, a pure, specific antithrombin could be more effective than heparin in the treatment of deep vein thrombosis, but its short half-life requires constant intravenous infusion, whereas subcutaneous administration of recombinant hirudin can ensure stable and prolonged plasma levels. The aim o...

    journal_title：Thrombosis and haemostasis

    pub_type： 临床试验,杂志文章

    doi：

    authors： Schiele F,Vuillemenot A,Kramarz P,Kieffer Y,Soria J,Soria C,Camez A,Mirshahi MC,Bassand JP

    更新日期：1994-05-01 00:00:00